DRUG PRESCRIBING IN PATIENTS WITH ACUTE RESPIRATORY INFECTIONS AT THE TAROGONG HEALTH CENTER, GARUT DISTRICT
DOI:
https://doi.org/10.33482/jmedfarm.v1i01.5Kata Kunci:
ISPA, Prescribing, Public Health CenterAbstrak
Acute respiratory infection is a major cause of infectious disease morbidity and mortality in the world. ARI is an acute inflammation of the upper and lower respiratory tract caused by microbial, bacterial or viral infection without or with lung parenchyma. ARI has a disease group with the highest absenteeism rate compared to other disease groups and is also suffered by many people. The purpose of this study was to determine the description of drug prescribing in patients with acute respiratory infections at the Tarogong Health Center, Garut Regency. This research using descriptive methods with retrospective data collection, data collection is done by simple random sampling technique. The results of this study were patients with ISPA, which were mostly female patients with a percentage of 52.98percent as
many as 142 people and men with a percentage of 47.01percent as many as 126 people. The data sample regarding the age of late adolescence 17 untill 25 years is the most cases with a percentage of 22.38 percent as many as 60 people. Based on the classification of ARI drugs that are more widely used are antibiotics with a percentage of 29.77percent as many as 268 people, analgesics-antipyretics with a percentage of 27.44percent as many as 247 people, expectorants with a percentage of 20.33 percent as many as 183 people, antihistamines with a percentage of 13.22percent as many as 119 people, corticosteroids with a percentage of 8.22percent as many as 74 people, bronchodilators with a percentage of 1 percent as many as 9 people.
Based on the type of ISPA the most widely used drugs were amoxicillin with a percentage of 71.26 percent as many as 191 people, paracetamol with a percentage of 70.89 percent as many as 190 people, chlorpheniramine maleate with a percentage of 36.94percent as many as 99 people. From these data, it can be concluded that female late adulthood suffers from ISPA, the most widely used drugs are amoxicillin, paracetamol, chlorpheniramine maleate, glyceryl guaiacolate, salbutamol and dexamethasone
Referensi
Albrecht, H H., Peter V. Dicpinigaitis, and
Eric P. Guenin. 2017. Role of
guaifenesin in the management of
chronic bronchitis and upper
respiratory tract infections. US
National Library of Medicine National
Institutes of Health. USA.
Badan Penelitian dan Pengembangan
Kesehatan. 2018. Laporan Nasional
Riskesdas 2018.Jakarta: Kementerian
Kesehatan RI.
Depkes RI, 2006. Pedoman
Penyelenggaraan dan Prosedur Rekam
Medis Rumah Sakit di Indonesia.
Jakarta : Depkes RI.
Halimah. 2019. Kondisi Lingkungan Rumah
Pada Balita Penderita Infeksi Saluran
Pernafasan Akut ( ISPA ) di Desa Teke
Kecamatan Palibelo Kabupaten Bima
Tahun 2019. Tersedia dalam
http://repository.poltekeskupang.ac.id.
Jalil, R. 2018. Faktor-faktor yang
Berhubungan Dengan Kejadian ISPA
Pada Balita di Wilayah Kerja
Puskesmas Kabangka Kecamatan
Kabangka Kabupaten Muna. Tersedia
dalam http://ojs.uho.ac.id. .
Kiran Mayuresh., Lalit Pawaskar and Shruthi
George. 2017. Efficacy And Safety For
A Combination Of Paracetamol,
Chlorpheniramine Maleate,
Phenylephrine, Sodium Citrate And
Menthol In The Symptomatic
Treatment Of Common Cold And
Allergic Rhinitis: Phase Iv Clinical
STUDY. International Journal of
Current Medical and Pharmaceutical
Research.
Kunoli J Firdaus. (2013). Pengantar
Epidemiologi Penyakit Menular :
Untuk Mahasiswa Kesehatan
Masyarakat. Jakarta : Cv. Trans Info
Media.
Kurniawan H, 2017. Kajian Pola Peresepan
Obat Infeksi Saluran Pernafasan Akut
di Puskesmas Bah Kapul Kota
Pematangsiantar Tahun 2017. TunasTunas Riset Kesehatan, Volume 7
Nomor Khusus Hari Ibu, Desember 2017.
Lubis Ira, I., Ferusgel, 2019. Hubungan
Kondisi Fisik Rumah dan Keberadaan
Perokok dalam Rumah dengan
Kejadian ISPA pada Balita di Desa
Silo Bonto, Kecamatan Silau Laut,
Kabupaten Asahan . Jurnal Ilmiah
Kesehatan Masyarakat, 11, 166–173.
Diakses tanggal 10 September 2019.
Maakh Yorida Febry, Ivonne Laning, Rambu
Tattu. 2017. Profil Pengobatan Infeksi
Saluran Pernapasan Akut (ISPA) Pada
Balita Di Puskesmas. Rambangaru
Tahun 2015. Jurnal Info Kesehatan.
Farmasi, Poltekkes Kemenkes Kupang.
Notoatmodjo Soekidjo. 2012. Metodologi
Penelitian Kesehatan (Revisi;
Soekidjo Notoatmodjo, ed.). Jakarta:
PT. RINEKA CIPTA
Noviantari Dwi. 2018. Gambaran
Karakteristik Balita dan Kondisi
Lingkungan Dalam Ruangan Terhadap
Keluhan Gejala ISPA di Taman
Penitipan Anak. Tersedia dalam
http://repository.uinjkt.ac.id.
Peraturan Menteri Kesehatan Republik
Indonesia Nomor 43 Tahun 2019
Tentang Pusat Kesehatan Masyarakat.
Jakarta : Menteri Kesehatan Republik
Indonesia,
Peraturan Menteri Kesehatan Republik
Indonesia Nomor 72 Tahun 2016
Tentang Standar Pelayanan
Kefarmasian Di Rumah Sakit . Jakarta
: Menteri Kesehatan Republik
Indonesia,
Peraturan Menteri Kesehatan Republik
Indonesia Nomor 74 Tahun 2016
Tentang Standar Pelayanan
Kefarmasian Di Puskesmas. Jakarta :
Menteri Kesehatan Republik
Indonesia,
Peraturan Menteri Kesehatan Republik
Indonesia Nomor 82 tahun 2014
Tentang Penanggulangan Penyakit
Menular. Jakarta : Menteri Kesehatan
Republik Indonesia.
Putra, Y & Wulandari, S.S. 2019. Faktor
Penyebab Kejadian Ispa. Jurnal
Kesehatan : Stikes Prima Nusantara
Bukittinggi - VOL. 10 NO. 01 (2019)
-40.
Ranantha, R., Eni Mahawati., Krishwiharsi
Kun., 2012. Hubungan Antara
Karakteristik Balita dengan Kejadian
ISPA Pada Balita di Desa Gandon
Kecamatan Kaloran KabupatenTemanggung. Karya Tulis Ilmiah.
Fakultas Kesehatan Masyarakat
.Universitas Dian Nuswantoro.
Semarang
Rosana, E. N. 2016. Faktor Risiko Kejadian
ISPA Pada Balita Ditinjau Dari
Lingkungan Dalam Rumah di Wilayah
Kerja Puskesmas Blado 1. Tersedia
dalam https://lib.unnes.ac.id.
Undang Undang Nomor 36 Tahun 2009.
Tentang Kesehatan
World Health Organization (WHO) tahun
Pusat Pengobatan ISPA Berat
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2023 LP4M STIKes Karsa Husada Garut

Artikel ini berlisensi Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.








